This page was printed from the Northern & Eastern Devon Formulary and Referral site at

Please ensure you are using the current version of this document

nhs logo
North & East Devon Formulary and Referral
  • Homepage
  • Formulary
    • Chapters
    • Committee
    • Information
    • Updates
    • COVID-19 Updates
  • Referral
    • Key messages
    • COVID - 19
    • Policies
    • Eastern locality
    • Northern locality
  • Urgent Care
    • Diabetes and Endocrinology Services
    • Maternity and EPS - Early Pregnancy Services
    • MAUs - Medical Assessment Units
    • Neurology Services
    • Older People / Frailty Services
    • Ophthalmology Services
    • Paediatric Assessment Units
    • Respiratory Services
    • Surgical Assessment Units
  • Learning

6. Endocrine

  • Type 2 diabetes mellitus treatment guidance
  • Management of thyroid disorders
  • Management of osteoporosis
  • Guidance on the management of menopause
  • Gender dysphoria and transgender prescribing
  • 6.1 Drugs used in diabetes
  • 6.2 Thyroid and antithyroid drugs
  • 6.3 Corticosteroids
  • 6.4 Sex hormones
  • 6.5 Hypothalamic and pituitary hormones and anti-oestrogens
  • 6.6 Drugs affecting bone metabolism
  • 6.7 Other endocrine drugs

6.1 Drugs used in diabetes

  • 6.1.1 Insulins
  • 6.1.2 Antidiabetic drugs
  • 6.1.4 Treatment of hypoglycaemia
  • 6.1.6 Diagnostic and monitoring devices for diabetes mellitus
  • 6.1.7 Continuous Glucose Monitors (CGM)


 

Home > Formulary > Chapters > 6. Endocrine > 6.1 Drugs used in diabetes

 

  • First line
  • Second line
  • Specialist
  • Hospital
  • Learning
  • Urgent Care
  • Referral
  • Formulary
Apple App Store Google Play Store
Return to Devon-wide Homepage | Apple App Store | Google Play Store
Accessibility | Contact Formulary | Cookies & Privacy | Referral feedback
Website designed & developed by the CEMO Team, NEW Devon CCG, built by Reactor15